ArticleThe Journal of experimental medicine1996

Transgenic expression of the Ly49A natural killer cell receptor confers class I major histocompatibility complex (MHC)-specific inhibition and prevents bone marrow allograft rejection.

W Held et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.